Smith C I Edvard, Bergman Peter, Hagey Daniel W
Department of Laboratory Medicine, Biomolecular and Cellular Medicine and Translational Research Center Karolinska (TRACK), Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital Huddinge, Stockholm, Sweden.
iScience. 2022 Jul 1;25(8):104698. doi: 10.1016/j.isci.2022.104698. eCollection 2022 Aug 19.
At the dawn of the personalized medicine era, the number of rare diseases has been estimated at 10,000. By considering the influence of environmental factors together with genetic variations and our improved diagnostic capabilities, an assessment suggests a considerably larger number. The majority would be extremely rare, and hence, we introduce the term "hyper-rare," defined as affecting <1/10 individuals. Such disorders would potentially outnumber all currently known rare diseases. Because autosomal recessive disorders are likely concentrated in consanguineous populations, and rare toxicities in rural areas, establishing their existence necessitates a greater reach than is currently viable. Moreover, the randomness of X-linked and gain-of-function mutations greatly compound this challenge. However, whether diseases actually cause a will depend on if their pathological mechanisms interact (phenotype conversion) or not (phenotype maintenance). The hyper-rare disease concept will be important in precision medicine with improved diagnosis and treatment of rare disease patients.
在个性化医疗时代之初,据估计罕见病的数量为10000种。综合考虑环境因素、基因变异以及我们不断提高的诊断能力后,一项评估表明实际数量要多得多。其中大多数极为罕见,因此,我们引入了“超罕见”这一术语,定义为发病率低于十万分之一。这类疾病的数量可能超过目前所有已知的罕见病。由于常染色体隐性疾病可能集中在近亲通婚人群中,而罕见毒性则出现在农村地区,要确定它们的存在需要比目前可行范围更大的覆盖面。此外,X连锁突变和功能获得性突变的随机性极大地加剧了这一挑战。然而,这些疾病是否真的会导致某种情况,将取决于它们的病理机制是否相互作用(表型转换)或不相互作用(表型维持)。超罕见病的概念对于精准医疗以及改善罕见病患者的诊断和治疗将具有重要意义。